Results 231 to 240 of about 28,797 (249)

Evaluating an RSV inhibitor

Nature Reviews Microbiology, 2022
exaly  

Monotherapy with a P2Y12 inhibitor or aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and meta-analysis

Lancet, The, 2020
Mauro Chiarito, Francesco Cannata, Davide Cao   +2 more
exaly  

Selective Loss of PARG Restores PARylation and Counteracts PARP Inhibitor-Mediated Synthetic Lethality

Cancer Cell, 2018
Ewa Gogola, Wouter W Wiegant, Daniel J Vis   +2 more
exaly  

Cyclins (A, B, D1, E) and cyclin dependent kinase inhibitors (p16, p21) expression in the liver of thioacetamide intoxicated rats

Journal of Hepatology, 2001
S.E. Theocharis, H. Kanelli, A. Margeli, A. Koutselinis   +3 more
openaire   +2 more sources

Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial

Lancet, The, 2010
Uri Lopatin, Patrick F Smith
exaly  

Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial

Lancet, The, 2011
Klemens Budde, Claudia Sommerer, Petra Reinke   +2 more
exaly  

SWITCH TO AROMATASE INHIBITOR BETTER THAN CONTINUING TAMOXIFEN

Ca-A Cancer Journal for Clinicians, 2005
exaly  

Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: acohort study

Lancet, The, 1999
Katherine Samaras, Donald J Chisholm
exaly  

Expression of the cyclin‐dependent kinase inhibitors p16^INK4, p15^INK4B and p21Waf1/cip1 in human breast cancer

, 1995
Elizabeth A. Musgrove, Richard Liuschkis, Ann L. Cornish, Christine S. L. Lee, Vittal Setlur, R. Seshadri, Robert L. Sutherland   +6 more
openalex   +1 more source

Hereditary angioedema with normal C1-inhibitor activity in women

Lancet, The, 2000
Konrad Bork
exaly